Boston Biotech Business Development Conference

Boston Biotech Business Development Conference

Speaking Engagement
The Boston Biotech Business Development Conference is a networking forum for industry professionals offering exclusive access to key decision-makers who influence deal-making and investment in the life sciences. Attendees will gain insights from presentations and panels featuring business development decision-makers from several of the world's leading pharmaceutical and biotechnology companies on the current and future outlook for licensing, M&A and other business development activities in the life sciences sector. In addition to sharing insights on what it takes to get a deal done in biotech, the conference will also offer opportunities to network one-on-one with the industry's top deal makers, including senior executives from biotech and pharma, leaders from Wall Street and venture capitalists.

WilmerHale Partner Hal Leibowitz will moderate a panel titled “M&A Activity in 2013: Who Benefits Most, Pharma or Biotech?” on Tuesday, April 2 from 4–4:30 p.m., and WilmerHale Partner David Redlick will moderate a panel titled “The Deals of Tomorrow: Predictions and Wish Lists” on Wednesday, April 3 from 3–3:30 p.m.

Read More About the Event

Speakers